These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9516852

  • 1. Expression and function of Trk-C in favourable human neuroblastomas.
    Yamashiro DJ, Liu XG, Lee CP, Nakagawara A, Ikegaki N, McGregor LM, Baylin SB, Brodeur GM.
    Eur J Cancer; 1997 Oct; 33(12):2054-7. PubMed ID: 9516852
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
    Svensson T, Rydén M, Schilling FH, Dominici C, Sehgal R, Ibáñez CF, Kogner P.
    Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
    [Abstract] [Full Text] [Related]

  • 3. Expression and function of TRK-B and BDNF in human neuroblastomas.
    Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM.
    Mol Cell Biol; 1994 Jan; 14(1):759-67. PubMed ID: 8264643
    [Abstract] [Full Text] [Related]

  • 4. Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study.
    Nakagawara A, Brodeur GM.
    Eur J Cancer; 1997 Oct; 33(12):2050-3. PubMed ID: 9516851
    [Abstract] [Full Text] [Related]

  • 5. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
    Rydén M, Sehgal R, Dominici C, Schilling FH, Ibáñez CF, Kogner P.
    Br J Cancer; 1996 Sep; 74(5):773-9. PubMed ID: 8795581
    [Abstract] [Full Text] [Related]

  • 6. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.
    Kramer K, Cheung NK, Gerald WL, LaQuaglia M, Kushner BH, LeClerc JM, LeSauter L, Saragovi HU.
    Eur J Cancer; 1997 Oct; 33(12):2098-100. PubMed ID: 9516861
    [Abstract] [Full Text] [Related]

  • 7. Expression of TrkC in favorable human neuroblastomas.
    Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM.
    Oncogene; 1996 Jan 04; 12(1):37-41. PubMed ID: 8552397
    [Abstract] [Full Text] [Related]

  • 8. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
    Tanaka T, Hiyama E, Sugimoto T, Sawada T, Tanabe M, Ida N.
    Cancer; 1995 Sep 15; 76(6):1086-95. PubMed ID: 8625212
    [Abstract] [Full Text] [Related]

  • 9. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 10. Expression of the nerve growth factor receptor c-TRK in human myeloid leukaemia cells.
    Kaebisch A, Brokt S, Seay U, Lohmeyer J, Jaeger U, Pralle H.
    Br J Haematol; 1996 Oct 25; 95(1):102-9. PubMed ID: 8857945
    [Abstract] [Full Text] [Related]

  • 11. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
    Azar CG, Scavarda NJ, Nakagawara A, Brodeur GM.
    Prog Clin Biol Res; 1994 Oct 25; 385():169-75. PubMed ID: 7972209
    [Abstract] [Full Text] [Related]

  • 12. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2.
    Hishiki T, Nimura Y, Isogai E, Kondo K, Ichimiya S, Nakamura Y, Ozaki T, Sakiyama S, Hirose M, Seki N, Takahashi H, Ohnuma N, Tanabe M, Nakagawara A.
    Cancer Res; 1998 May 15; 58(10):2158-65. PubMed ID: 9605760
    [Abstract] [Full Text] [Related]

  • 13. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC.
    J Natl Cancer Inst; 1993 Mar 03; 85(5):377-84. PubMed ID: 8433391
    [Abstract] [Full Text] [Related]

  • 14. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
    Miyake M, Suzuki T, Shimada H, Stram D, Seeger RC.
    Prog Clin Biol Res; 1994 Mar 03; 385():163-8. PubMed ID: 7972208
    [No Abstract] [Full Text] [Related]

  • 15. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
    Lavenius E, Gestblom C, Johansson I, Nånberg E, Påhlman S.
    Cell Growth Differ; 1995 Jun 03; 6(6):727-36. PubMed ID: 7669728
    [Abstract] [Full Text] [Related]

  • 16. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G.
    Prog Clin Biol Res; 1994 Jun 03; 385():137-45. PubMed ID: 7972205
    [Abstract] [Full Text] [Related]

  • 17. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.
    Cancer Res; 1992 Mar 01; 52(5):1364-8. PubMed ID: 1737399
    [Abstract] [Full Text] [Related]

  • 18. Abundant but inactive-state gp140proto-trk is expressed in neuroblastomas of patients with good prognosis.
    Iwata H, Ito T, Mutoh T, Ishiguro Y, Xiao H, Hamaguchi M.
    Jpn J Cancer Res; 1994 Jan 01; 85(1):32-9. PubMed ID: 7508904
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of phosphorylation of TrkB and TrkC and their signal transduction by alpha2-macroglobulin.
    Hu YQ, Koo PH.
    J Neurochem; 1998 Jul 01; 71(1):213-20. PubMed ID: 9648868
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
    Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, Brodeur GM.
    Cancer Res; 1995 Apr 15; 55(8):1792-7. PubMed ID: 7712489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.